Jacobsen Biotech ApS

CVR 43211218 · Private limited company (ApS) · Active · Medium risk

Jacobsen Biotech ApS is a Private limited company (ApS), founded on , based in Harlev J. The company is registered in the industry ikke-finansielle holdingselskaber. Our model estimates a bankruptcy risk of 1.4% over the next 12 months, which is 1.0 times the average for Danish companies. 4 annual reports have been published. The latest annual report (31 Dec 2025) shows equity of DKK 14k and a net result of DKK -7,890. CEO: Kristian Mark Jacobsen.

Bankruptcy risk for Jacobsen Biotech ApS

1.4%
probability of bankruptcy within 12 months
Medium risk

1.0 × the average (1.41%) · higher risk than 77% of active Danish companies

Lowest riskHighest risk

Increases the risk

Return on assets< -20% · bankruptcy rate 16.7%1.9×
Going-concern uncertaintyYes · bankruptcy rate 16.3%1.9×
Time at current address1 yrs · bankruptcy rate 14.0%1.6×
Age (years)3–5 yrs · bankruptcy rate 13.3%1.5×
Moves in the last 2 years1 · bankruptcy rate 12.7%1.4×
Number of auditors (historical)0 · bankruptcy rate 12.5%1.4×
Published annual reports3–5 · bankruptcy rate 11.7%1.3×
Equity vs. share capital0–0.5× · bankruptcy rate 11.1%1.3×

Reduces the risk

Equity ratio60%+ · bankruptcy rate 3.3%0.38×
Negative equityNo · bankruptcy rate 5.1%0.58×
Share of late annual reports< 0.01% · bankruptcy rate 5.2%0.59×
Current ratio150%–200% · bankruptcy rate 5.4%0.61×
Auditor's statementCompilation · bankruptcy rate 5.6%0.64×
Reporting classReporting class B · bankruptcy rate 5.7%0.65×
Industry changes1 · bankruptcy rate 6.5%0.74×
RegionMidtjylland · bankruptcy rate 6.9%0.79×

The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.

Company details

CVR number
43211218
Status
Active
Company type
Private limited company (ApS)
Founded
(4 years)
Address
Tåstrup Søvej 4
8462 Harlev J
Municipality
Aarhus
Industry
Ikke-finansielle holdingselskaber (642120)
Bankruptcies in the industry: Fremstilling af farmaceutiske præparater
Share capital
DKK 40k
Auditor
Sønderup Godkendt Revisionsaktieselskab
Audit opted out
Yes

Warning signs

Annual reports filed late0 of 4
Missing annual reportNo
Negative equityNo
Equity ratio73.8%
Current ratio182%
Moves (last 2 years)1
CEO changes in total0
CEO's previous bankruptcies0
Other companies at the address0
Going-concern uncertaintyYes

Financials and key figures

Financial year202520242023
Revenue–DKK 0DKK 4,000
Gross profitDKK -7,890DKK -2,890DKK -15k
Net profitDKK -7,890DKK -2,872DKK -18k
EquityDKK 14kDKK 22kDKK 25k
Total assetsDKK 19kDKK 22kDKK 25k
CashDKK 9,103DKK 12k–
Short-term debtDKK 5,000––
Avg. employees0––

Latest annual report: Reporting class B · auditor's statement: Andre erklæringer uden sikkerhed · Sønderup Godkendt Revisionsaktieselskab.

Filed annual reports

Reporting periodPublishedDays after period end
1 Jan 2025 – 31 Dec 2025142
1 Jan 2024 – 31 Dec 2024147
1 Jan 2023 – 31 Dec 2023179
21 Apr 2022 – 31 Dec 202253

The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.

Management, owners and auditor

RoleNameFromTo
CEOKristian Mark JacobsenCurrent
Owner (100%)Kristian Mark JacobsenCurrent
FounderKristian Mark JacobsenCurrent

The CEOs' other companies

Kristian Mark Jacobsen – 1 other companies

Address history (1 moves)

Tåstrup Søvej 4, 8462 Harlev J
Tåstrup Søvej 4, 8462 Harlev J

Similar companies in Aarhus

Questions and answers about Jacobsen Biotech ApS

Has Jacobsen Biotech ApS gone bankrupt?

No, Jacobsen Biotech ApS is not registered as bankrupt in the CVR register. Its status is: active.

What is the bankruptcy risk of Jacobsen Biotech ApS?

Our model estimates a bankruptcy risk of 1.4% over the next 12 months (medium risk), which is 1.0 times the average for Danish companies.

Who is the CEO of Jacobsen Biotech ApS?

Kristian Mark Jacobsen is the CEO of Jacobsen Biotech ApS.

Who is the auditor of Jacobsen Biotech ApS?

Jacobsen Biotech ApS most recently used Sønderup Godkendt Revisionsaktieselskab.

When was Jacobsen Biotech ApS founded?

Jacobsen Biotech ApS was founded on 21 April 2022.

What is the equity of Jacobsen Biotech ApS?

Equity was DKK 14k according to the annual report for the period ending 31 December 2025.

Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.